Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Eledon Pharmaceuticals

Market Cap: US$173.1m

Operates as a clinical stage biotechnology company.

ProQR Therapeutics

Market Cap: US$169.4m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Anika Therapeutics

Market Cap: US$166.9m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Avacta Group

Market Cap: UK£126.5m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

AC Immune

Market Cap: US$166.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Prime Medicine

Market Cap: US$166.2m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Japan Tissue Engineering

Market Cap: JP¥24.4b

Engages in the regenerative medicine business in Japan.

Genovis AB (publ.)

Market Cap: SEK 1.6b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Heidelberg Pharma

Market Cap: €148.2m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Fennec Pharmaceuticals

Market Cap: US$164.2m

Operates as a commercial stage biopharmaceutical company in the United States.

Nanobiotix

Market Cap: €147.4m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

TriSalus Life Sciences

Market Cap: US$162.0m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.

INmune Bio

Market Cap: US$161.8m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Esperion Therapeutics

Market Cap: US$158.2m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Sangamo Therapeutics

Market Cap: US$157.3m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Organigram Global

Market Cap: CA$219.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

DiaMedica Therapeutics

Market Cap: US$156.9m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

hVIVO

Market Cap: UK£117.4m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Molecular Partners

Market Cap: CHF 130.4m

A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.

enGene Holdings

Market Cap: US$150.9m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Inhibikase Therapeutics

Market Cap: US$148.7m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Cybin

Market Cap: US$148.3m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Race Oncology

Market Cap: AU$231.1m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

OSE Immunotherapeutics

Market Cap: €133.0m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Korro Bio

Market Cap: US$146.1m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

4D Molecular Therapeutics

Market Cap: US$142.7m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

SELLAS Life Sciences Group

Market Cap: US$141.7m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Egetis Therapeutics

Market Cap: SEK 1.4b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Sensorion

Market Cap: €126.0m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Diaceutics

Market Cap: UK£105.6m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

Eupraxia Pharmaceuticals

Market Cap: CA$193.6m

A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

Nkarta

Market Cap: US$136.9m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Aclaris Therapeutics

Market Cap: US$136.4m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Larimar Therapeutics

Market Cap: US$135.7m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Protalix BioTherapeutics

Market Cap: US$134.2m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Rapid Micro Biosystems

Market Cap: US$133.2m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.